Factors Associated with Survival Among Adults with HIV-Associated TB in Guangxi, China: A Retrospective Cohort Study

• Recommendations of the Interim Policy on Collaborative TB/HIV activities. Wkly Epidemiol. Rec.79(1–2) , 6–11 (2004).
   PubMedGoogle Scholar
• Ngowi BJ , MfinangaSG, BruunJN, MorkveO. Pulmonary tuberculosis among people living with HIV/AIDS attending care and treatment in rural northern Tanzania. BMC Public Health8 , 341 (2008).
   PubMed Web of Science ®Google Scholar
• Cain KP , KanaraN, LasersonKF et al. The epidemiology of HIV-associated tuberculosis in rural Cambodia. Int. J. Tuberc. Lung Dis. 11(9) , 1008–1013 (2007).
   PubMed Web of Science ®Google Scholar
• Lawn SD , ChurchyardG. Epidemiology of HIV-associated tuberculosis. Curr. Opin. HIV AIDS4(4) , 325–333 (2009).
   PubMed Web of Science ®Google Scholar
• Harries A , MaherD, GrahamS. TB/HIV: A Clinical Manual. Second Edition. WHO Geneva, Switzerland (2004).
   Google Scholar
• Varma JK , NateniyomS, AkksilpS et al. HIV care and treatment factors associated with improved survival during TB treatment in Thailand: an observational study. BMC Infect. Dis. 9 , 42 (2009).
   PubMed Web of Science ®Google Scholar
• Dean GL , EdwardsSG, IvesNJ et al. Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy. AIDS 16(1) , 75–83 (2002).
   PubMed Web of Science ®Google Scholar
• Dheda K , LampeFC, JohnsonMA, LipmanMC. Outcome of HIV-associated tuberculosis in the era of highly active antiretroviral therapy. J. Infect. Dis.190(9) , 1670–1676 (2004).
   PubMed Web of Science ®Google Scholar
• Akksilp S , KarnkawinpongO, WattanaamornkiatW et al. Antiretroviral therapy during tuberculosis treatment and marked reduction in death rate of HIV-infected patients, Thailand. Emerg. Infect. Dis. 13(7) , 1001–1007 (2007).
   PubMed Web of Science ®Google Scholar
• Manosuthi W , ChottanapandS, ThongyenS, ChaovavanichA, SungkanuparphS. Survival rate and risk factors of mortality among HIV/tuberculosis-coinfected patients with and without antiretroviral therapy. J. Acquir. Immune Defic. Syndr.43(1) , 42–46 (2006).
   PubMed Web of Science ®Google Scholar
• Trinh TT , ShahNS, MaiHA et al. HIV-associated TB in An Giang Province, Vietnam, 2001–2004: epidemiology and TB treatment outcomes. PLoS One 2(6) , e507 (2007).
   PubMed Web of Science ®Google Scholar
• Quy HT , CobelensFG, LanNT, BuuTN, LambregtsCS, BorgdorffMW. Treatment outcomes by drug resistance and HIV status among tuberculosis patients in Ho Chi Minh City, Vietnam. Int. J. Tuberc. Lung Dis.10(1) , 45–51 (2006).
   PubMed Web of Science ®Google Scholar
• Lu L , JiaM, MaY et al. The changing face of HIV in China. Nature 455(7213) , 609–611 (2008).
   PubMed Web of Science ®Google Scholar
• Shen X , DeriemerK, YuanZA et al. Drug-resistant tuberculosis in Shanghai, China, 2000–2006: prevalence, trends and risk factors. Int. J. Tuberc. Lung Dis. 13(2) , 253–259 (2009).
   PubMed Web of Science ®Google Scholar
• Wang L , LiuW, WangY, WuZ. HIV prevalence among pulmonary tuberculosis patients in Guangxi, China. J. Acquir. Immune Defic. Syndr.53(Suppl. 1) , S61–S65 (2010).
   PubMed Web of Science ®Google Scholar
• Ngamlert K , SinthuwattanawiboolC, McCarthyKD et al. Diagnostic performance and costs of Capilia TB for Mycobacterium tuberculosis complex identification from broth-based culture in Bangkok, Thailand. Trop. Med. Int. Health 14(7) , 748–753 (2009).
   PubMed Web of Science ®Google Scholar
• Sungkanuparph S , EampokalapB, ChottanapundS, ThongyenS, ManosuthiW. Impact of drug-resistant tuberculosis on the survival of HIV-infected patients. Int. J. Tuberc. Lung Dis.11(3) , 325–330 (2007).
   PubMed Web of Science ®Google Scholar
• Podlekareva DN , MocroftA, PostFA et al. Mortality from HIV and TB coinfections is higher in Eastern Europe than in Western Europe and Argentina. AIDS 23(18) , 2485–2495 (2009).
   PubMed Web of Science ®Google Scholar
• Liu X , ThomsonR, GongY et al. How affordable are tuberculosis diagnosis and treatment in rural China? An analysis from community and tuberculosis patient perspectives. Trop. Med. Int. Health 12(12) , 1464–1471 (2007).
   PubMed Web of Science ®Google Scholar
• Getahun H , HarringtonM, O‘BrienR, NunnP. Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changes. Lancet369(9578) , 2042–2049 (2007).
   PubMed Web of Science ®Google Scholar
• Velasco M , CastillaV, SanzJ et al. Effect of simultaneous use of highly active antiretroviral therapy on survival of HIV patients with tuberculosis. J. Acquir. Immune Defic. Syndr. 50(2) , 148–152 (2009).
   PubMed Web of Science ®Google Scholar
• Hung CC , ChenMY, HsiaoCF, HsiehSM, ShengWH, ChangSC. Improved outcomes of HIV-1-infected adults with tuberculosis in the era of highly active antiretroviral therapy. AIDS17(18) , 2615–2622 (2003).
   PubMed Web of Science ®Google Scholar
• Sanguanwongse N , CainKP, SuriyaP et al. Antiretroviral therapy for HIV-infected tuberculosis patients saves lives but needs to be used more frequently in Thailand. J. Acquir. Immune Defic. Syndr. 48(2) , 181–189 (2008).
   PubMed Web of Science ®Google Scholar
• Raizada N , ChauhanLS, BabuBS et al. Linking HIV-infected TB patients to cotrimoxazole prophylaxis and antiretroviral treatment in India. PLoS One 4(6) , e5999 (2009).
   PubMed Web of Science ®Google Scholar
• Nunn AJ , MwabaP, ChintuC, MwingaA, DarbyshireJH, ZumlaA. Role of co-trimoxazole prophylaxis in reducing mortality in HIV infected adults being treated for tuberculosis: randomised clinical trial. BMJ337 , a257 (2008).
   PubMedGoogle Scholar
• Wiktor SZ , Sassan-MorokroM, GrantAD et al. Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1-infected patients with tuberculosis in Abidjan, Cote d‘Ivoire: a randomised controlled trial. Lancet 353(9163) , 1469–1475 (1999).
   PubMed Web of Science ®Google Scholar
• WHO. Anti-Retroviral Therapy for HIV Infection in Adults and Adolescents: Recommendations for a Public Health Approach. WHO, Geneva, Switzerland (2006).
   Google Scholar
• Manosuthi W , SungkanuparphS, TantanathipP et al. A randomized trial comparing plasma drug concentrations and efficacies between 2 nonnucleoside reverse-transcriptase inhibitor-based regimens in HIV-infected patients receiving rifampicin: the N2R Study. Clin. Infect. Dis. 48(12) , 1752–1759 (2009).
   PubMed Web of Science ®Google Scholar
• Shipton LK , WesterCW, StockS et al. Safety and efficacy of nevirapine- and efavirenz-based antiretroviral treatment in adults treated for TB-HIV co-infection in Botswana. Int. J. Tuberc. Lung Dis. 13(3) , 360–366 (2009).
   PubMed Web of Science ®Google Scholar
• Manosuthi W , MankatithamW, LueangniyomkulA, ChimsuntornS, SungkanuparphS. Standard-dose efavirenz vs. standard-dose nevirapine in antiretroviral regimens among HIV-1 and tuberculosis co-infected patients who received rifampicin. HIV Med.9(5) , 294–299 (2008).
   PubMed Web of Science ®Google Scholar
• Zhang Y , LuL, LiHQ et al. Engaging HIV-infected patients in antiretroviral therapy services: CD4 cell count testing after HIV diagnosis from 2005 to 2009 in Yunnan and Guangxi, China. Chin. Med. J. (Engl.) 124(10) , 1488–1492 (2011).
   PubMed Web of Science ®Google Scholar
• Zhang F , DouZ, MaY et al. Five-year outcomes of the China National Free Antiretroviral Treatment Program. Ann. Intern. Med. 151(4) , 241–251, W-52 (2009).
   PubMed Web of Science ®Google Scholar
• Cain KP , MccarthyKD, HeiligCM et al. An algorithm for tuberculosis screening and diagnosis in people with HIV. N. Engl. J. Med. 362(8) , 707–716 (2010).
   PubMed Web of Science ®Google Scholar
• Fischl MA , DaikosGL, UttamchandaniRB et al. Clinical presentation and outcome of patients with HIV infection and tuberculosis caused by multiple-drug-resistant bacilli. Ann. Intern. Med. 117(3) , 184–190 (1992).
   PubMed Web of Science ®Google Scholar
• Espinal MA , LaszloA, SimonsenL et al. Global trends in resistance to antituberculosis drugs. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. N. Engl. J. Med. 344(17) , 1294–1303 (2001).
   PubMed Web of Science ®Google Scholar
• Alexander PE , DeP. The emergence of extensively drug-resistant tuberculosis (TB): TB/HIV coinfection, multidrug-resistant TB and the resulting public health threat from extensively drug-resistant TB, globally and in Canada. Can. J. Infect. Dis. Med. Microbiol.18(5) , 289–291 (2007).
   PubMed Web of Science ®Google Scholar
• Wright A , ZignolM, Van Deun A et al. Epidemiology of antituberculosis drug resistance 2002–2007: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Lancet373(9678) , 1861–1873 (2009).
   PubMed Web of Science ®Google Scholar
• Havlir DV , KendallMA, IveP et al. Timing of antiretroviral therapy for HIV-1 infection and tuberculosis. N. Engl. J. Med. 365(16) , 1482–1491 (2011).
   PubMed Web of Science ®Google Scholar
• Blanc FX , SokT, LaureillardD et al. Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis. N. Engl. J. Med. 365(16) , 1471–1481 (2011).
   PubMed Web of Science ®Google Scholar
• Friedland G , ChurchyardGJ, NardellE. Tuberculosis and HIV coinfection: current state of knowledge and research priorities. J. Infect. Dis.196(Suppl. 1) , S1–S3 (2007).
   PubMed Web of Science ®Google Scholar

Websites

• WHO. Global tuberculosis control: a short update to the 2009 report. www.who.int/tb/publications/global_report/2009/ update/en/index.html (Accessed May2012)
   Google Scholar
• The World Bank. China: Tuberculosis Control Project. www.worldbank.org/ en/news/2010/09/24/china-tuberculosis-control-project0 (Accessed May2012)
   Google Scholar